Latest analysis of U.S. real-world evidence demonstrates improved clinical outcomes when cefiderocol is used as earlier ...
The field hockey star uses the sam® sustained acoustic medicine device from ZetrOZ Systems to manage knee osteoarthritis, ...
Management to Showcase Full Nature-Cide Product Line at Industry's Flagship Event LOS ANGELES, CA / ACCESS Newswire / October ...
Five-year strategy positions the iconic Lifeline brand to reach one million older adults through a connected healthcare ...
Prolong Pharmaceuticals, LLC (the Company), a clinical-stage biopharmaceutical company, today announced that it will present key clinical data from HEMERA-1, its Phase 1/2 clinical trial in Acute ...
Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo –– ...
In the rapidly evolving pharmaceutical landscape, drug discovery services have become a pivotal axis around which innovation, ...
The clinical laboratory services market is entering a phase of sustained expansion, fueled by evolving healthcare dynamics, ...
Zoliflodacin, an investigational single-dose oral antibiotic for uncomplicated gonorrhea, to be featured in oral presentation ...
KIVU-107 is the first PTK7-targeting ADC with a DAR4 exatecan payload, engineered for exceptional stability and highly selective on-tumor delivery.Preclinical data demonstrate deeper and durable ...
Funding accelerates development of novel therapeutics to improve outcomes for patients with cancerCAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--#ADC--Valink Therapeutics Inc. (“Valink”), a private ...
New $25 million raise advances multi-node PI3K program; randomized phase 2 trial with Gynecologic Oncology Group Foundation now enrollingAUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback